Dr. Marc Siegel, a medical contributor for Fox News, sheds light on AstraZeneca’s acknowledgment of possible side effects from their COVID vaccine. He emphasizes the significance of regular movement, advocating for individuals to take breaks every 30 minutes.
AstraZeneca, the pharmaceutical giant, announced on Tuesday that it is globally withdrawing its COVID-19 vaccine due to low demand and the abundance of other updated vaccines available since the pandemic.
Vaxzevria, one of the vaccines available in the market, was developed by pharmaceutical companies to protect individuals from contracting COVID-19.
Vaxzevria’s marketing authorizations within Europe will be withdrawn by the company, as announced. However, it is important to note that the vaccine did not receive approval from the FDA in the United States.
Poland Requests Pfizer to Renegotiate COVID-19 Vaccine Deal
According to AstraZeneca, their vaccine has been supplied globally with over 3 billion doses. They also claim that the vaccine has saved over 6.5 million lives in just the first year of its use.
The company stated that with the development of multiple COVID-19 vaccines, there is now an excess of available updated vaccines. This surplus has resulted in a decrease in demand for Vaxzevria, which is no longer being produced or distributed.
According to AstraZeneca, they have supplied over 3 billion doses globally, resulting in the saving of over 6.5 million lives in just the first year of use.
According to the Guardian, the statement mentioned that governments worldwide have acknowledged and valued our efforts as a crucial factor in bringing an end to the global pandemic. The statement further stated that we will collaborate with regulators and our partners to establish a clear roadmap for the future, thereby making a significant contribution in addressing the COVID-19 pandemic.
Vaccine manufacturers experience a surge in stock prices due to the Biden administration’s push for COVID vaccinations.
The global pharmaceutical company, AstraZeneca, announced on Tuesday that it is withdrawing its COVID-19 vaccine from the market due to low demand and an abundance of alternative vaccines available.
AstraZeneca has recently acknowledged, for the first time in court documents, that its COVID-19 vaccine can result in rare side effects, including blood clots and low blood platelet counts. This admission was made during a U.K. class action lawsuit where nearly 50 individuals sought compensation of $125 million for suffering adverse reactions to the AstraZeneca vaccine.
In 2021, the European Medicines Agency updated the product information for Vaxzevria to include a warning about Guillain-Barré syndrome, which is listed as a very rare side effect.
According to the Telegraph, the firm made their application to withdraw the vaccine on March 5, and it became effective on Tuesday.
According to the Guardian, Australia has not had access to the vaccine since March 2023. However, its use had already been gradually phased out since June 2021 as newer vaccines became more widely available. This decision to discontinue the vaccine was made by many countries even before Tuesday’s announcement.
AstraZeneca, a London-listed company, expanded its portfolio by venturing into respiratory syncytial virus vaccines and obesity drugs. This strategic move came after experiencing a decline in growth due to the decrease in sales of COVID-19 medicine.